dalteparin has been researched along with fidexaban in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hicks, GW; Janiczek-Dolphin, N; Juneau, PL; Leadley, R; McClanahan, TB; Mertz, TE; Morrison, AL; Morser, J; Peng, YW; Sullivan, ME | 1 |
Chesebro, JH; Karnicki, K; Leadley, RJ; McBane, RD; Miller, RS; Morser, J; Owen, WG | 1 |
2 other study(ies) available for dalteparin and fidexaban
Article | Year |
---|---|
The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosis.
Topics: Amidines; Animals; Anticoagulants; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrolysis; Enoxaparin; Factor Xa Inhibitors; Partial Thromboplastin Time; Prothrombin Time; Pyridines; Thrombin Time; Thrombosis; Time Factors; Venous Thrombosis | 2001 |
Inhibition and reversal of platelet-rich arterial thrombus in vivo: direct vs. indirect factor Xa inhibition.
Topics: Amidines; Animals; Anticoagulants; Blood Platelets; Carotid Arteries; Carotid Artery Thrombosis; Dose-Response Relationship, Drug; Enoxaparin; Factor Xa Inhibitors; Female; Heparin; Inhibitory Concentration 50; Perfusion; Prothrombin Time; Pyridines; Swine; Thrombosis; Time Factors | 2004 |